Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Minerva Neurosciences, Inc (NERV) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-125.40M |
|
-- |
|
-- |
|
$16.67M |
|
$-16.67M |
|
$-108.73M |
|
$-125.40M |
|
$-125.40M |
|
$-125.40M |
|
$-125.40M |
|
$-125.40M |
|
$-125.40M |
|
$-16.67M |
|
$-16.81M |
|
43.90M |
|
43.90M |
|
$-2.86 |
|
$-2.86 |
|
| Balance Sheet Financials | |
$79.11M |
|
-- |
|
$14.92M |
|
$94.03M |
|
$4.48M |
|
-- |
|
$343.56M |
|
$348.04M |
|
$-254.01M |
|
$-268.88M |
|
$-254.01M |
|
43.84M |
|
| Cash Flow Statement Financials | |
$-5.43M |
|
$-45.29M |
|
$1.08M |
|
$82.40M |
|
$32.76M |
|
$-49.64M |
|
$8.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.65 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
49.37% |
|
46.64% |
|
-133.37% |
|
49.37% |
|
$-5.79 |
|
$-0.12 |
|
$-0.12 |
|